Page last updated: 2024-10-29

ketamine and Dejerine-Roussy Syndrome

ketamine has been researched along with Dejerine-Roussy Syndrome in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Research Excerpts

ExcerptRelevanceReference
"Ketamine was then tested as a potential therapeutic drug."1.39Bilateral central pain sensitization in rats following a unilateral thalamic lesion may be treated with high doses of ketamine. ( Beaudry, F; Castel, A; Hélie, P; Vachon, P, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Castel, A1
Hélie, P1
Beaudry, F1
Vachon, P1

Other Studies

1 other study available for ketamine and Dejerine-Roussy Syndrome

ArticleYear
Bilateral central pain sensitization in rats following a unilateral thalamic lesion may be treated with high doses of ketamine.
    BMC veterinary research, 2013, Mar-27, Volume: 9

    Topics: Analgesics; Animals; Disease Models, Animal; Hemorrhage; Hyperalgesia; Ketamine; Pain Measurement; R

2013